821 Views | 1,134 Downloads
Corresponding author: Banu Aygun, MD Steven and Alexandra Cohen Children's Medical Center of NY Division of Pediatric Hematology/Oncology and Stem Cell Transplantation 269-01 76th Avenue, Suite 255 New Hyde Park, NY 11040 Tel. (718) 470-3095/ Fax (718) 343-2961 baygun@nshs.edu.
BA, NAM, WHS, ARC,OA, ZRR, JLK, STM, PS, RI, PAL, REW and the SWiTCH Trial investigators performed the research.
REW, NAM, WHS, BA designed the research study.
BA, NAM, KK, AL, REW analysed the data.
BA, REW, NAM, KK, AL, WHS, ARC,OA, ZRR, JLK, STM, PS, RI, PAL wrote the paper.
We thank the SWITCH personnel at the participating clinical centres listed in the Appendix, as well as the children and their families for their commitment.
The authors have no competing interests.
The SWiTCH Clinical Trial was supported by the National Heart, Lung and Blood Institute of the National Institutes of Health (grants U01-HL078787 to REW and U01-HL078987 to Ronald W. Helms at Rho) and Novartis Inc. for donation of deferasirox for study participants on the Standard Treatment Arm.
© 2015 John Wiley & Sons Ltd.